Sigachi Industries profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−14.6%−14.6%13.5%16.4%16.2%
−9.8%−9.8%9.2%10.7%11.7%
5.9%5.9%14.4%16.4%17.4%
4.5%5.3%8.7%9.5%14.1%
Margins
9.8%11.3%20.5%19.2%19.4%
7.6%7.6%17.3%16.5%17.3%
—461.7%20.6%14.2%—
5.0%−18.4%18.9%17.5%18.0%
5.6%−17.3%14.4%14.4%14.4%
5.4%−17.1%14.2%14.3%14.4%
−7.7%−7.7%−3.4%−18.1%−23.7%
Additional
−12.5%5.6%23.7%17.9%20.1%
—−4.6%4.7%5.4%7.1%
−14.6%−15.2%12.9%15.5%15.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SIGACHI₹26.60

Sigachi Industries Limited

· Pharma & Health
₹ CrorePeersLINCOLNTHEMISMEDBAJAJHCAREAMRUTANJANJAGSNPHARMWANBURYNGLFINEMcap ₹1,016 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity16.2216.3813.50-14.57-14.57
Return on Assets11.6510.739.15-9.81-9.81
Return on Capital Employed17.4216.3514.435.875.87
Return on Invested Capital14.119.548.715.314.49
Margins
EBITDA Margin19.4419.2120.4811.259.80
Operating Margin17.2516.5117.257.577.57
Incremental Operating Margin—14.1920.56461.74—
Pretax Margin18.0417.4918.91-18.354.97
Net Income Margin14.4114.3514.43-17.335.59
Net Income to Common Margin14.4114.3314.25-17.115.38
FCF Margin-23.74-18.12-3.36-7.71-7.71
Additional
Effective Tax Rate20.0917.9223.685.58-12.50
Dvd Payout Ratio7.065.374.66-4.61—
Sustainable Growth Rate15.0715.5012.87-15.24-14.57
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.